French start-up to advance development of automated microfluidic cell and gene therapy manufacturing platform
Astraveus raises €16.5 Million Series Seed round
03-Jul-2023 -
Astraveus SAS, the creator of modular, microfluidic cell foundries that transform cell and gene therapy (CGT) manufacturing, exited stealth with the completion of an oversubscribed €16.5 million Series Seed financing led by AdBio partners, co-syndicated with M Ventures, Johnson & Johnson ...
cell therapies
gene therapy
microfluidics
+1